SBHMY
Price:
$11.27
Market Cap:
$70.72B
Sino Biopharmaceutical Limited operates as a prominent research and development-centric pharmaceutical conglomerate in the People's Republic of China, functioning as an investment holding company. Its operations are organized into three primary divisions: Modernized Chinese and Chemical Medicines, Investment activities, and other varied business ventures. The firm maintains an extensive product range covering numerous therapeutic categories. Among its offerings are oncology treatments, such as Qingkeshu tablets and Leweixin injections; cardiovascular and cerebrovascular medications, including Kaina and Anrixin tablets; hepatitis remedies like Tianqingganmei injections; and orthopedic solutio...[Read more]
Industry
Biotechnology
IPO Date
2017-09-05
Stock Exchange
OTC
Ticker
SBHMY
According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current ROE is 7.24%. This represents a change of 242.97% compared to the average of 2.11% of the last 4 quarters.
The mean historical ROE of Sino Biopharmaceutical Limited over the last ten years is 19.07%. The current 7.24% ROE has changed -62.01% with respect to the historical average. Over the past ten years (40 quarters), SBHMY's ROE was at its highest in in the June 2021 quarter at 26.72%. The ROE was at its lowest in in the December 2025 quarter at -1.70%.
Average
19.07%
Median
15.82%
Minimum
7.64%
Maximum
48.23%
Discovering the peaks and valleys of Sino Biopharmaceutical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 191.46%
Maximum Annual ROE = 48.23%
Minimum Annual Increase = -82.27%
Minimum Annual ROE = 7.64%
| Year | ROE | Change |
|---|---|---|
| 2025 | 7.64% | -30.26% |
| 2024 | 10.95% | 43.10% |
| 2023 | 7.65% | -10.51% |
| 2022 | 8.55% | -82.27% |
| 2021 | 48.23% | 191.46% |
| 2020 | 16.55% | 9.66% |
| 2019 | 15.09% | -51.27% |
| 2018 | 30.97% | 31.36% |
| 2017 | 23.57% | 9.47% |
| 2016 | 21.53% | -6.10% |
The current ROE of Sino Biopharmaceutical Limited (SBHMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.75%
5-year avg
16.60%
10-year avg
19.07%
Sino Biopharmaceutical Limited’s ROE is less than WuXi Biologics (Cayman) Inc. (10.64%), less than WuXi Biologics (Cayman) Inc. (10.64%), less than Genmab A/S (14.53%), less than Innovent Biologics, Inc. (4.82%), less than Straumann Holding AG (16.90%), less than Straumann Holding AG (16.90%), less than Orion Oyj (48.73%), less than Astellas Pharma Inc. (17.44%), less than Astellas Pharma Inc. (17.44%), less than bioMérieux S.A. (9.89%),
| Company | ROE | Market cap |
|---|---|---|
| 10.64% | $18.23B | |
| 10.64% | $15.37B | |
| 14.53% | $15.30B | |
| 4.82% | $16.58B | |
| 16.90% | $20.39B | |
| 16.90% | $20.33B | |
| 48.73% | $21.95B | |
| 17.44% | $24.01B | |
| 17.44% | $23.83B | |
| 9.89% | $9.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sino Biopharmaceutical Limited's ROE?
How is the ROE calculated for Sino Biopharmaceutical Limited (SBHMY)?
What is the highest ROE for Sino Biopharmaceutical Limited (SBHMY)?
What is the 3-year average ROE for Sino Biopharmaceutical Limited (SBHMY)?
What is the 5-year average ROE for Sino Biopharmaceutical Limited (SBHMY)?
How does the current ROE for Sino Biopharmaceutical Limited (SBHMY) compare to its historical average?